Chronic back pain, especially in middle-age, can develop for several reasons, including degenerative disc disease, nerve root irritation, arthritis or a slipped vertebrae ... These techniques usually ...
UCB, a global biopharmaceutical company, today announced the start of BE BOLD, a head-to-head Phase 3b study, comparing BIMZELX® (bimekizumab-bkzx), an interleukin (IL)-17A and IL-17F inhibitor, with ...